Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22403047 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Condition: Aneurysmal Subarachnoid Hemorrhage
Interventions: Drug: Clazosentan;   Drug: Placebo

Indicates status has not been verified in more than two years